Drug Patent Expirations in May 2015

Drug Patent Expirations for May 2015

Tradename Applicant Generic Name Patent Number Patent Expiration
ACCUPRIL Pfizer Pharms quinapril hydrochloride 5,684,016*PED May 4, 2015
INTEGRILIN Schering eptifibatide 5,747,447 May 5, 2015
LIPTRUZET Merck Sharp Dohme atorvastatin calcium; ezetimibe 5,686,104*PED May 11, 2015
LIPITOR Pfizer atorvastatin calcium 5,686,104*PED May 11, 2015
CADUET Pfizer amlodipine besylate; atorvastatin calcium 5,686,104*PED May 11, 2015
AFREZZA Sanofi Aventis insulin recombinant human 6,071,497 May 15, 2015
AFREZZA Sanofi Aventis insulin recombinant human 6,428,771 May 15, 2015
AFREZZA Sanofi Aventis insulin recombinant human 8,394,414 May 15, 2015
RISPERDAL CONSTA Janssen Pharms risperidone 5,688,801*PED May 18, 2015
SANDOSTATIN LAR Novartis octreotide acetate 5,688,530*PED May 18, 2015
ZYVOX Pharmacia And Upjohn linezolid 5,688,792*PED May 18, 2015
ASMANEX TWISTHALER Merck Sharp Dohme mometasone furoate 5,687,710*PED May 18, 2015
MACUGEN Valeant Pharms Llc pegaptanib sodium 6,051,698 May 19, 2015
LIVALO Kowa Co pitavastatin calcium 5,753,675 May 19, 2015
OCTREOSCAN Mallinckrodt indium in-111 pentetreotide kit 5,753,627 May 19, 2015
NEXIUM 24HR Astrazeneca Lp esomeprazole magnesium 5,690,960*PED May 25, 2015
NEXIUM Astrazeneca Pharms esomeprazole magnesium 5,690,960*PED May 25, 2015
EGRIFTA Theratechnologies tesamorelin acetate 5,861,379 May 26, 2015
ABLAVAR Lantheus Medcl gadofosveset trisodium 8,017,105 May 26, 2015
EGRIFTA Theratechnologies tesamorelin acetate 6,020,311 May 26, 2015
ABLAVAR Lantheus Medcl gadofosveset trisodium 7,229,606 May 26, 2015
ABLAVAR Lantheus Medcl gadofosveset trisodium 7,060,250 May 26, 2015
NEXIUM IV Astrazeneca Pharms esomeprazole sodium 6,143,771 May 27, 2015
SKIN EXPOSURE REDUCTION PASTE AGAINST CHEMICAL WARFARE AGENTS Us Army perfluoropolymethylisopropyl ether; polytetrafluoroethylene 5,607,979 May 30, 2015
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

Subscribers have access to valuable datasets, including:

  • Clinical trial information
  • International patent families
  • International patent priority and PCT information
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Dynamic search capabilities with data export
  • More…
See the Database Preview and Plan Comparison.

Contact Us with any questions.
Click here for reuse options!
Copyright 2015 Biotechblog

Comments are closed.

%d bloggers like this: